141 related articles for article (PubMed ID: 34581923)
1. Vacuum-Assisted Breast Biopsy After Neoadjuvant Systemic Treatment for Reliable Exclusion of Residual Cancer in Breast Cancer Patients.
Koelbel V; Pfob A; Schaefgen B; Sinn P; Feisst M; Golatta M; Gomez C; Stieber A; Bach P; Rauch G; Heil J
Ann Surg Oncol; 2022 Feb; 29(2):1076-1084. PubMed ID: 34581923
[TBL] [Abstract][Full Text] [Related]
2. Intelligent Vacuum-Assisted Biopsy to Identify Breast Cancer Patients With Pathologic Complete Response (ypT0 and ypN0) After Neoadjuvant Systemic Treatment for Omission of Breast and Axillary Surgery.
Pfob A; Sidey-Gibbons C; Rauch G; Thomas B; Schaefgen B; Kuemmel S; Reimer T; Hahn M; Thill M; Blohmer JU; Hackmann J; Malter W; Bekes I; Friedrichs K; Wojcinski S; Joos S; Paepke S; Degenhardt T; Rom J; Rody A; van Mackelenbergh M; Banys-Paluchowski M; Große R; Reinisch M; Karsten M; Golatta M; Heil J
J Clin Oncol; 2022 Jun; 40(17):1903-1915. PubMed ID: 35108029
[TBL] [Abstract][Full Text] [Related]
3. Diagnosing Pathologic Complete Response in the Breast After Neoadjuvant Systemic Treatment of Breast Cancer Patients by Minimal Invasive Biopsy: Oral Presentation at the San Antonio Breast Cancer Symposium on Friday, December 13, 2019, Program Number GS5-03.
Heil J; Pfob A; Sinn HP; Rauch G; Bach P; Thomas B; Schaefgen B; Kuemmel S; Reimer T; Hahn M; Thill M; Blohmer JU; Hackmann J; Malter W; Bekes I; Friedrichs K; Wojcinski S; Joos S; Paepke S; Ditsch N; Rody A; Große R; van Mackelenbergh M; Reinisch M; Karsten M; Golatta M;
Ann Surg; 2022 Mar; 275(3):576-581. PubMed ID: 32657944
[TBL] [Abstract][Full Text] [Related]
4. Accuracy of Post-Neoadjuvant Chemotherapy Image-Guided Breast Biopsy to Predict Residual Cancer.
Tasoulis MK; Lee HB; Yang W; Pope R; Krishnamurthy S; Kim SY; Cho N; Teoh V; Rauch GM; Smith BD; Valero V; Mohammed K; Han W; MacNeill F; Kuerer HM
JAMA Surg; 2020 Dec; 155(12):e204103. PubMed ID: 33026457
[TBL] [Abstract][Full Text] [Related]
5. Minimally Invasive Breast Biopsy After Neoadjuvant Systemic Treatment to Identify Breast Cancer Patients with Residual Disease for Extended Neoadjuvant Treatment: A New Concept.
Pfob A; Cai L; Schneeweiss A; Rauch G; Thomas B; Schaefgen B; Kuemmel S; Reimer T; Hahn M; Thill M; Blohmer JU; Hackmann J; Malter W; Bekes I; Friedrichs K; Wojcinski S; Joos S; Paepke S; Degenhardt T; Rom J; Rody A; van Mackelenbergh M; Banys-Paluchowski M; Große R; Reinisch M; Karsten MM; Sidey-Gibbons C; Wallwiener M; Golatta M; Heil J
Ann Surg Oncol; 2024 Feb; 31(2):957-965. PubMed ID: 37947974
[TBL] [Abstract][Full Text] [Related]
6. RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial.
Heil J; Sinn P; Richter H; Pfob A; Schaefgen B; Hennigs A; Riedel F; Thomas B; Thill M; Hahn M; Blohmer JU; Kuemmel S; Karsten MM; Reinisch M; Hackmann J; Reimer T; Rauch G; Golatta M
BMC Cancer; 2018 Aug; 18(1):851. PubMed ID: 30144818
[TBL] [Abstract][Full Text] [Related]
7. Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy?
Heil J; Schaefgen B; Sinn P; Richter H; Harcos A; Gomez C; Stieber A; Hennigs A; Rauch G; Schuetz F; Sohn C; Schneeweiss A; Golatta M
Eur J Cancer; 2016 Dec; 69():142-150. PubMed ID: 27821317
[TBL] [Abstract][Full Text] [Related]
8. A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy.
Kuerer HM; Rauch GM; Krishnamurthy S; Adrada BE; Caudle AS; DeSnyder SM; Black DM; Santiago L; Hobbs BP; Lucci A; Gilcrease M; Hwang RF; Candelaria RP; Chavez-MacGregor M; Smith BD; Arribas E; Moseley T; Teshome M; Miggins MV; Valero V; Hunt KK; Yang WT
Ann Surg; 2018 May; 267(5):946-951. PubMed ID: 28549010
[TBL] [Abstract][Full Text] [Related]
9. Omission of Breast Surgery in Predicted Pathologic Complete Response after Neoadjuvant Systemic Therapy: A Multicenter, Single-Arm, Non-inferiority Trial.
Jung JJ; Cheun JH; Kim SY; Koh J; Ryu JM; Yoo TK; Shin HC; Ahn SG; Park S; Lim W; Nam SE; Park MH; Kim KS; Kang T; Lee J; Youn HJ; Kim YS; Yoon CI; Kim HK; Moon HG; Han W; Cho N; Kim MK; Lee HB
J Breast Cancer; 2024 Feb; 27(1):61-71. PubMed ID: 38433091
[TBL] [Abstract][Full Text] [Related]
10. Identification of breast cancer patients with pathologic complete response in the breast after neoadjuvant systemic treatment by an intelligent vacuum-assisted biopsy.
Pfob A; Sidey-Gibbons C; Lee HB; Tasoulis MK; Koelbel V; Golatta M; Rauch GM; Smith BD; Valero V; Han W; MacNeill F; Weber WP; Rauch G; Kuerer HM; Heil J
Eur J Cancer; 2021 Jan; 143():134-146. PubMed ID: 33307491
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques.
Heil J; Kümmel S; Schaefgen B; Paepke S; Thomssen C; Rauch G; Ataseven B; Große R; Dreesmann V; Kühn T; Loibl S; Blohmer JU; von Minckwitz G
Br J Cancer; 2015 Dec; 113(11):1565-70. PubMed ID: 26554654
[TBL] [Abstract][Full Text] [Related]
12. Prediction of pathologic complete response using image-guided biopsy after neoadjuvant chemotherapy in breast cancer patients selected based on MRI findings: a prospective feasibility trial.
Lee HB; Han W; Kim SY; Cho N; Kim KE; Park JH; Ju YW; Lee ES; Lim SJ; Kim JH; Ryu HS; Lee DW; Kim M; Kim TY; Lee KH; Shin SU; Lee SH; Chang JM; Moon HG; Im SA; Moon WK; Park IA; Noh DY
Breast Cancer Res Treat; 2020 Jul; 182(1):97-105. PubMed ID: 32418044
[TBL] [Abstract][Full Text] [Related]
13. Imaging-Concordant Benign MRI-Guided Vacuum-Assisted Breast Biopsy May Not Warrant MRI Follow-Up.
Huang ML; Speer M; Dogan BE; Rauch GM; Candelaria RP; Adrada BE; Hess KR; Yang WT
AJR Am J Roentgenol; 2017 Apr; 208(4):916-922. PubMed ID: 28140609
[TBL] [Abstract][Full Text] [Related]
14. Eliminating Breast Surgery for Invasive Cancer with Exceptional Response to Neoadjuvant Systemic Therapy: Prospective Multicenter Clinical Trial Planned Initial Feasibility Endpoint.
Johnson HM; Valero V; Yang WT; Smith BD; Krishnamurthy S; Shen Y; Lin H; Lucci A; Rauch GM; Kuerer HM
J Am Coll Surg; 2023 Jul; 237(1):101-108. PubMed ID: 36856291
[TBL] [Abstract][Full Text] [Related]
15. Identifying pathologic complete response of the breast after neoadjuvant systemic therapy with ultrasound guided biopsy to eventually omit surgery: Study design and feasibility of the MICRA trial (Minimally Invasive Complete Response Assessment).
van der Noordaa MEM; van Duijnhoven FH; Loo CE; van Werkhoven E; van de Vijver KK; Wiersma T; Winter-Warnars HAO; Sonke GS; Vrancken Peeters MTFD
Breast; 2018 Aug; 40():76-81. PubMed ID: 29698928
[TBL] [Abstract][Full Text] [Related]
16. Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study.
van Loevezijn AA; van der Noordaa MEM; van Werkhoven ED; Loo CE; Winter-Warnars GAO; Wiersma T; van de Vijver KK; Groen EJ; Blanken-Peeters CFJM; Zonneveld BJGL; Sonke GS; van Duijnhoven FH; Vrancken Peeters MTFD
Ann Surg Oncol; 2021 Jun; 28(6):3243-3253. PubMed ID: 33263830
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node biopsy is not necessary in patients diagnosed with ductal carcinoma in situ of the breast by stereotactic vacuum-assisted biopsy.
Kotani H; Yoshimura A; Adachi Y; Ishiguro J; Hisada T; Ichikawa M; Gondou N; Hattori M; Kondou N; Sawaki M; Fujita T; Iwata H
Breast Cancer; 2016 Mar; 23(2):190-4. PubMed ID: 24989112
[TBL] [Abstract][Full Text] [Related]
18. Vacuum assisted breast biopsy (VAB) excision of subcentimeter microcalcifications as an alternative to open biopsy for atypical ductal hyperplasia.
Schiaffino S; Massone E; Gristina L; Fregatti P; Rescinito G; Villa A; Friedman D; Calabrese M
Br J Radiol; 2018 May; 91(1085):20180003. PubMed ID: 29451396
[TBL] [Abstract][Full Text] [Related]
19. Breast Microcalcifications: Diagnostic Outcomes According to Image-Guided Biopsy Method.
Bae S; Yoon JH; Moon HJ; Kim MJ; Kim EK
Korean J Radiol; 2015; 16(5):996-1005. PubMed ID: 26357494
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the underestimation rate in cases with ductal carcinoma in situ at ultrasound-guided core biopsy: 14-gauge automated core-needle biopsy vs 8- or 11-gauge vacuum-assisted biopsy.
Suh YJ; Kim MJ; Kim EK; Moon HJ; Kwak JY; Koo HR; Yoon JH
Br J Radiol; 2012 Aug; 85(1016):e349-56. PubMed ID: 22422382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
